We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
BCL2
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • BCL2
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

BCL2
Synonyms Bcl-2, PPP1R50
Gene descriptioni

Full gene name according to HGNC.

BCL2 apoptosis regulator
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Cancer-related genes
Disease related genes
FDA approved drug targets
Human disease related genes
Plasma proteins
Transporters
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular,Membrane
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 18
Cytoband q21.33
Chromosome location (bp) 63123346 - 63320128
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

5
Ensembl ENSG00000171791 (version 103.38)
Entrez gene 596
HGNC HGNC:990
UniProt P10415 (UniProt - Evidence at protein level)
neXtProt NX_P10415
Antibodypedia BCL2 antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 0      # Population variants: 131

Experimental


Description: Crystal structure of BCL-2 in complex with a BAX BH3 peptide (X-ray)

# Chains: 2      # Clinical variants: 0      # Population variants: 0

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
BCL2-201
BCL2-202
BCL2-203
BCL2-204
BCL2-208


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
BCL2-201
ENSP00000329623
ENST00000333681
P10415 [Direct mapping]
Apoptosis regulator Bcl-2
A0A024R2B3 [Target identity:100%; Query identity:100%]
Apoptosis regulator Bcl-2
Show all
Transporters
   Transporter channels and pores
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   # TM segments-based
   2TM proteins predicted by MDM
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the lung and pleura
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000209 [protein polyubiquitination]
GO:0001836 [release of cytochrome c from mitochondria]
GO:0002020 [protease binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005741 [mitochondrial outer membrane]
GO:0005783 [endoplasmic reticulum]
GO:0005789 [endoplasmic reticulum membrane]
GO:0006915 [apoptotic process]
GO:0006959 [humoral immune response]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0007565 [female pregnancy]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008625 [extrinsic apoptotic signaling pathway via death domain receptors]
GO:0008630 [intrinsic apoptotic signaling pathway in response to DNA damage]
GO:0009314 [response to radiation]
GO:0009636 [response to toxic substance]
GO:0010039 [response to iron ion]
GO:0010507 [negative regulation of autophagy]
GO:0015267 [channel activity]
GO:0016020 [membrane]
GO:0016021 [integral component of membrane]
GO:0016248 [channel inhibitor activity]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0022898 [regulation of transmembrane transporter activity]
GO:0030307 [positive regulation of cell growth]
GO:0030890 [positive regulation of B cell proliferation]
GO:0031625 [ubiquitin protein ligase binding]
GO:0031965 [nuclear membrane]
GO:0032469 [endoplasmic reticulum calcium ion homeostasis]
GO:0032848 [negative regulation of cellular pH reduction]
GO:0032991 [protein-containing complex]
GO:0034097 [response to cytokine]
GO:0035094 [response to nicotine]
GO:0042100 [B cell proliferation]
GO:0042493 [response to drug]
GO:0042802 [identical protein binding]
GO:0042803 [protein homodimerization activity]
GO:0042981 [regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043524 [negative regulation of neuron apoptotic process]
GO:0043565 [sequence-specific DNA binding]
GO:0046902 [regulation of mitochondrial membrane permeability]
GO:0046930 [pore complex]
GO:0046982 [protein heterodimerization activity]
GO:0050853 [B cell receptor signaling pathway]
GO:0051402 [neuron apoptotic process]
GO:0051434 [BH3 domain binding]
GO:0051607 [defense response to virus]
GO:0051881 [regulation of mitochondrial membrane potential]
GO:0051902 [negative regulation of mitochondrial depolarization]
GO:0051924 [regulation of calcium ion transport]
GO:0055085 [transmembrane transport]
GO:0070059 [intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress]
GO:0070491 [repressing transcription factor binding]
GO:0097192 [extrinsic apoptotic signaling pathway in absence of ligand]
GO:1900740 [positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway]
GO:1902166 [negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:2000811 [negative regulation of anoikis]
GO:2001234 [negative regulation of apoptotic signaling pathway]
GO:2001240 [negative regulation of extrinsic apoptotic signaling pathway in absence of ligand]
GO:2001243 [negative regulation of intrinsic apoptotic signaling pathway]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
239 aa
26.3 kDa
No 2
BCL2-202
ENSP00000381185
ENST00000398117
P10415 [Direct mapping]
Apoptosis regulator Bcl-2
A0A024R2B3 [Target identity:100%; Query identity:100%]
Apoptosis regulator Bcl-2
Show all
Transporters
   Transporter channels and pores
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   # TM segments-based
   2TM proteins predicted by MDM
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the lung and pleura
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000209 [protein polyubiquitination]
GO:0000902 [cell morphogenesis]
GO:0001503 [ossification]
GO:0001541 [ovarian follicle development]
GO:0001656 [metanephros development]
GO:0001657 [ureteric bud development]
GO:0001658 [branching involved in ureteric bud morphogenesis]
GO:0001662 [behavioral fear response]
GO:0001776 [leukocyte homeostasis]
GO:0001782 [B cell homeostasis]
GO:0001822 [kidney development]
GO:0001836 [release of cytochrome c from mitochondria]
GO:0001952 [regulation of cell-matrix adhesion]
GO:0002020 [protease binding]
GO:0002260 [lymphocyte homeostasis]
GO:0002320 [lymphoid progenitor cell differentiation]
GO:0002326 [B cell lineage commitment]
GO:0002360 [T cell lineage commitment]
GO:0002520 [immune system development]
GO:0002931 [response to ischemia]
GO:0003014 [renal system process]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005741 [mitochondrial outer membrane]
GO:0005783 [endoplasmic reticulum]
GO:0005789 [endoplasmic reticulum membrane]
GO:0005829 [cytosol]
GO:0006470 [protein dephosphorylation]
GO:0006582 [melanin metabolic process]
GO:0006808 [regulation of nitrogen utilization]
GO:0006874 [cellular calcium ion homeostasis]
GO:0006915 [apoptotic process]
GO:0006959 [humoral immune response]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006979 [response to oxidative stress]
GO:0007015 [actin filament organization]
GO:0007409 [axonogenesis]
GO:0007565 [female pregnancy]
GO:0007569 [cell aging]
GO:0008134 [transcription factor binding]
GO:0008283 [cell population proliferation]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008584 [male gonad development]
GO:0008625 [extrinsic apoptotic signaling pathway via death domain receptors]
GO:0008630 [intrinsic apoptotic signaling pathway in response to DNA damage]
GO:0008631 [intrinsic apoptotic signaling pathway in response to oxidative stress]
GO:0008637 [apoptotic mitochondrial changes]
GO:0009314 [response to radiation]
GO:0009636 [response to toxic substance]
GO:0009791 [post-embryonic development]
GO:0009887 [animal organ morphogenesis]
GO:0010039 [response to iron ion]
GO:0010224 [response to UV-B]
GO:0010332 [response to gamma radiation]
GO:0010468 [regulation of gene expression]
GO:0010506 [regulation of autophagy]
GO:0010507 [negative regulation of autophagy]
GO:0010523 [negative regulation of calcium ion transport into cytosol]
GO:0010559 [regulation of glycoprotein biosynthetic process]
GO:0014031 [mesenchymal cell development]
GO:0014042 [positive regulation of neuron maturation]
GO:0014911 [positive regulation of smooth muscle cell migration]
GO:0015267 [channel activity]
GO:0016020 [membrane]
GO:0016021 [integral component of membrane]
GO:0016248 [channel inhibitor activity]
GO:0018105 [peptidyl-serine phosphorylation]
GO:0018107 [peptidyl-threonine phosphorylation]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0019903 [protein phosphatase binding]
GO:0021747 [cochlear nucleus development]
GO:0022612 [gland morphogenesis]
GO:0022898 [regulation of transmembrane transporter activity]
GO:0030097 [hemopoiesis]
GO:0030183 [B cell differentiation]
GO:0030217 [T cell differentiation]
GO:0030279 [negative regulation of ossification]
GO:0030307 [positive regulation of cell growth]
GO:0030308 [negative regulation of cell growth]
GO:0030318 [melanocyte differentiation]
GO:0030336 [negative regulation of cell migration]
GO:0030890 [positive regulation of B cell proliferation]
GO:0031069 [hair follicle morphogenesis]
GO:0031103 [axon regeneration]
GO:0031625 [ubiquitin protein ligase binding]
GO:0031647 [regulation of protein stability]
GO:0031965 [nuclear membrane]
GO:0031966 [mitochondrial membrane]
GO:0032469 [endoplasmic reticulum calcium ion homeostasis]
GO:0032835 [glomerulus development]
GO:0032848 [negative regulation of cellular pH reduction]
GO:0032880 [regulation of protein localization]
GO:0032991 [protein-containing complex]
GO:0033033 [negative regulation of myeloid cell apoptotic process]
GO:0033077 [T cell differentiation in thymus]
GO:0033138 [positive regulation of peptidyl-serine phosphorylation]
GO:0033689 [negative regulation of osteoblast proliferation]
GO:0034097 [response to cytokine]
GO:0035094 [response to nicotine]
GO:0035265 [organ growth]
GO:0040008 [regulation of growth]
GO:0040018 [positive regulation of multicellular organism growth]
GO:0042100 [B cell proliferation]
GO:0042149 [cellular response to glucose starvation]
GO:0042493 [response to drug]
GO:0042542 [response to hydrogen peroxide]
GO:0042802 [identical protein binding]
GO:0042803 [protein homodimerization activity]
GO:0042981 [regulation of apoptotic process]
GO:0043029 [T cell homeostasis]
GO:0043066 [negative regulation of apoptotic process]
GO:0043067 [regulation of programmed cell death]
GO:0043085 [positive regulation of catalytic activity]
GO:0043209 [myelin sheath]
GO:0043375 [CD8-positive, alpha-beta T cell lineage commitment]
GO:0043473 [pigmentation]
GO:0043524 [negative regulation of neuron apoptotic process]
GO:0043565 [sequence-specific DNA binding]
GO:0043583 [ear development]
GO:0045069 [regulation of viral genome replication]
GO:0045636 [positive regulation of melanocyte differentiation]
GO:0045930 [negative regulation of mitotic cell cycle]
GO:0046671 [negative regulation of retinal cell programmed cell death]
GO:0046902 [regulation of mitochondrial membrane permeability]
GO:0046930 [pore complex]
GO:0046982 [protein heterodimerization activity]
GO:0048041 [focal adhesion assembly]
GO:0048066 [developmental pigmentation]
GO:0048070 [regulation of developmental pigmentation]
GO:0048087 [positive regulation of developmental pigmentation]
GO:0048536 [spleen development]
GO:0048538 [thymus development]
GO:0048545 [response to steroid hormone]
GO:0048546 [digestive tract morphogenesis]
GO:0048589 [developmental growth]
GO:0048599 [oocyte development]
GO:0048743 [positive regulation of skeletal muscle fiber development]
GO:0048753 [pigment granule organization]
GO:0048873 [homeostasis of number of cells within a tissue]
GO:0050790 [regulation of catalytic activity]
GO:0050853 [B cell receptor signaling pathway]
GO:0051384 [response to glucocorticoid]
GO:0051402 [neuron apoptotic process]
GO:0051434 [BH3 domain binding]
GO:0051607 [defense response to virus]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051881 [regulation of mitochondrial membrane potential]
GO:0051902 [negative regulation of mitochondrial depolarization]
GO:0051924 [regulation of calcium ion transport]
GO:0055085 [transmembrane transport]
GO:0070059 [intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress]
GO:0070491 [repressing transcription factor binding]
GO:0071310 [cellular response to organic substance]
GO:0071456 [cellular response to hypoxia]
GO:0072593 [reactive oxygen species metabolic process]
GO:0097192 [extrinsic apoptotic signaling pathway in absence of ligand]
GO:0098609 [cell-cell adhesion]
GO:1900740 [positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway]
GO:1902166 [negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:2000134 [negative regulation of G1/S transition of mitotic cell cycle]
GO:2000378 [negative regulation of reactive oxygen species metabolic process]
GO:2000811 [negative regulation of anoikis]
GO:2001234 [negative regulation of apoptotic signaling pathway]
GO:2001240 [negative regulation of extrinsic apoptotic signaling pathway in absence of ligand]
GO:2001243 [negative regulation of intrinsic apoptotic signaling pathway]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
239 aa
26.3 kDa
No 2
BCL2-203
ENSP00000466417
ENST00000589955
P10415 [Direct mapping]
Apoptosis regulator Bcl-2
A0A024R2C4 [Target identity:100%; Query identity:100%]
Apoptosis regulator Bcl-2
Show all
Transporters
   Transporter channels and pores
   MEMSAT3 predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the lung and pleura
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000209 [protein polyubiquitination]
GO:0001836 [release of cytochrome c from mitochondria]
GO:0002020 [protease binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005741 [mitochondrial outer membrane]
GO:0005783 [endoplasmic reticulum]
GO:0005789 [endoplasmic reticulum membrane]
GO:0006915 [apoptotic process]
GO:0006959 [humoral immune response]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0007565 [female pregnancy]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008625 [extrinsic apoptotic signaling pathway via death domain receptors]
GO:0008630 [intrinsic apoptotic signaling pathway in response to DNA damage]
GO:0009314 [response to radiation]
GO:0009636 [response to toxic substance]
GO:0010039 [response to iron ion]
GO:0010507 [negative regulation of autophagy]
GO:0015267 [channel activity]
GO:0016020 [membrane]
GO:0016021 [integral component of membrane]
GO:0016248 [channel inhibitor activity]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0022898 [regulation of transmembrane transporter activity]
GO:0030307 [positive regulation of cell growth]
GO:0030890 [positive regulation of B cell proliferation]
GO:0031625 [ubiquitin protein ligase binding]
GO:0031965 [nuclear membrane]
GO:0032469 [endoplasmic reticulum calcium ion homeostasis]
GO:0032848 [negative regulation of cellular pH reduction]
GO:0032991 [protein-containing complex]
GO:0034097 [response to cytokine]
GO:0035094 [response to nicotine]
GO:0042100 [B cell proliferation]
GO:0042493 [response to drug]
GO:0042802 [identical protein binding]
GO:0042803 [protein homodimerization activity]
GO:0042981 [regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043524 [negative regulation of neuron apoptotic process]
GO:0043565 [sequence-specific DNA binding]
GO:0046902 [regulation of mitochondrial membrane permeability]
GO:0046930 [pore complex]
GO:0046982 [protein heterodimerization activity]
GO:0050853 [B cell receptor signaling pathway]
GO:0051402 [neuron apoptotic process]
GO:0051434 [BH3 domain binding]
GO:0051607 [defense response to virus]
GO:0051881 [regulation of mitochondrial membrane potential]
GO:0051902 [negative regulation of mitochondrial depolarization]
GO:0051924 [regulation of calcium ion transport]
GO:0055085 [transmembrane transport]
GO:0070059 [intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress]
GO:0070491 [repressing transcription factor binding]
GO:0097192 [extrinsic apoptotic signaling pathway in absence of ligand]
GO:1900740 [positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway]
GO:1902166 [negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:2000811 [negative regulation of anoikis]
GO:2001234 [negative regulation of apoptotic signaling pathway]
GO:2001240 [negative regulation of extrinsic apoptotic signaling pathway in absence of ligand]
GO:2001243 [negative regulation of intrinsic apoptotic signaling pathway]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
205 aa
22.3 kDa
No 0
BCL2-204
ENSP00000503945
ENST00000590515
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the lung and pleura
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
Protein evidence (Ezkurdia et al 2014)
Show all
46 aa
5.1 kDa
No 0
BCL2-208
ENSP00000504546
ENST00000678301
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the lung and pleura
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
Protein evidence (Ezkurdia et al 2014)
Show all
52 aa
5.7 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.